HIV-1 gene expression: Lessons from provirus and non-integrated DNA

Retrovirology

Volumn 1, Issue , 2004, Pages

  Wu, Yuntao ^a  

^a GEORGE MASON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; REV PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS DNA; VIRUS RNA;

CHROMATIN; DNA INTEGRATION; DNA TRANSCRIPTION; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; NONHUMAN; PROTEIN PROTEIN INTERACTION; PROVIRUS; REVERSE TRANSCRIPTION; REVIEW; VIRUS REPLICATION; ANIMAL; GENETIC TRANSCRIPTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; LIFE CYCLE STAGE; VIRUS DNA CELL DNA INTERACTION;

ANIMALS; DNA, VIRAL; GENE EXPRESSION REGULATION, VIRAL; HIV-1; HUMANS; LIFE CYCLE STAGES; PROVIRUSES; TRANSCRIPTION, GENETIC; VIRUS INTEGRATION;

EID: 4344634285     PISSN: 17424690     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-4690-1-13     Document Type: Review

References (106)

1. Nisole S, Saib A: Early steps of retrovirus replication cycle. Retrovirology 2004, 1:9.
2. Donehower LA, Varmus HE: A mutant murine leukemia virus with a single missense codon in pol is defective in a function affecting integration. Proc Natl Acad Sci U S A 1984, 81:6461-6465.
3. List J, Haase AT: Integration of visna virus DNA occurs and may be necessary for productive infection. Virology 1997, 237:189-197.
4. Wiskerchen M, Muesing MA: Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. J Virol 1995, 69:376-386.
5. Engelman A, Englund G, Orenstein JM, Martin MA, Craigie R: Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol 1995, 69:2729-2736.
6. Nakajima N, Lu R, Engelman A: Human immunodeficiency virus type 1 replication in the absence of integrase-mediated dna recombination: definition of permissive and nonpermissive T-cell lines. J Virol 2001, 75:7944-7955.
7. Gaur M, Leavitt AD: Mutations in the human immunodeficiency virus type 1 integrase D,D(35)E motif do not eliminate provirus formation. J Virol 1998, 72:4678-4685.
8. Rohdewohld H, Weiher H, Reik W, Jaenisch R, Breindl M: Retrovirus integration and chromatin structure: Moloney murine leukemia proviral integration sites map near DNase I-hypersensitive sites. J Virol 1987, 61:336-343.
9. King W, Patel MD, Lobel LI, Goff SP, Nguyen-Huu MC: Insertion mutagenesis of embryonal carcinoma cells by retroviruses. Science 1985, 228:554-558.
10. Schroder A, Shinn P, Chen H, Berry C, Ecker J, Bushman F: HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots. Cell 2002, 110:521.
11. Weidhaas JB, Angelichio EL, Fenner S, Coffin JM: Relationship between retroviral DNA integration and gene expression. J Virol 2000, 74:8382-8389.
12. Jordan A, Bisgrove D, Verdin E: HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J 2003, 22:1868-1877.
13. Verdin E: DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1. J Virol 1991, 65:6790-6799.
14. Steger DJ, Workman JL: Stable co-occupancy of transcription factors and histones at the HIV-1 enhancer. Embo J 1997, 16:2463-2472.
15. Verdin E, Paras P., Jr., Van Lint C: Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. Embo J 1993, 12:3249-3259.
16. Demarchi F, D'Agaro P, Falaschi A, Giacca M: In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1. J Virol 1993, 67:7450-7460.
17. el Kharroubi A, Verdin E: Protein-DNA interactions within DNase I-hypersensitive sites located downstream of the HIV-1 promoter. J Biol Chem 1994, 269:19916-19924.
18. Rosen CA, Sodroski JG, Haseltine WA: The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 1985, 41:813-823.
19. Siekevitz M, Josephs SF, Dukovich M, Peffer N, Wong-Staal F, Greene WC: Activation of the HIV-1 LTR by T cell mitogens and the transactivator protein of HTLV-I. Science 1987, 238:1575-1578.
20. Pereira LA, Bentley K, Peeters A, Churchill MJ, Deacon NJ: A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res 2000, 28:663-668.
21. Sheldon M, Ratnasabapathy R, Hernandez N: Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs. Mol Cell Biol 1993, 13:1251-1263.
22. Ratnasabapathy R, Sheldon M, Johal L, Hernandez N: The HIV-1 long terminal repeat contains an unusual element that induces the synthesis of short RNAs from various mRNA and snRNA promoters. Genes Dev 1990, 4:2061-2074.
23. Berkhout B, Gatignol A, Rabson AB, Jeang KT: TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter. Cell 1990, 62:757-767.
24. Jordan A, Defechereux P, Verdin E: The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. Embo J 2001, 20:1726-1738.
25. Jeang KT, Chun R, Lin NH, Gatignol A, Glabe CG, Fan H: In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J Virol 1993, 67:6224-6233.
26. Benkirane M, Chun RF, Xiao H, Ogryzko VV, Howard BH, Nakatani Y, Jeang KT: Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J Biol Chem 1998, 273:24898-24905.
27. Marzio G, Tyagi M, Gutierrez MI, Giacca M: HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc Natl Acad Sci U S A 1998, 95:13519-13524.
28. Hottiger MO, Nabel GJ: Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein. J Virol 1998, 72:8252-8256.
29. Okada M, Jeang KT: Differential requirements for activation of integrated and transiently transfected human T-cell leukemia virus type 1 long terminal repeat. J Virol 2002, 76:12564-12573.
30. Kamine J, Elangovan B, Subramanian T, Coleman D, Chinnadurai G: Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator. Virology 1996, 216:357-366.
31. Col E, Caron C, Seigneurin-Berny D, Gracia J, Favier A, Khochbin S: The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat. J Biol Chem 2001, 276:28179-28184.
32. Kashanchi F, Shibata R, Ross EK, Brady JN, Martin MA: Second-site long terminal repeat (LTR) revertants of replication- defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA. J Virol 1994, 68:3298-3307.
33. Berkhout B, Silverman RH, Jeang KT: Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 1989, 59:273-282.
34. Rana TM, Jeang KT: Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA. Arch Biochem Biophys 1999, 365:175-185.
35. Karn J: Tackling Tat. J Mol Biol 1999, 293:235-254.
36. Garber ME, Jones KA: HIV-1 Tat: coping with negative elongation factors. Curr Opin Immunol 1999, 11:460-465.
37. Herrmann CH, Rice AP: Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology 1993, 197:601-608.
38. Herrmann CH, Rice AP: Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J Virol 1995, 69:1612-1620.
39. Zhu Y, Pe'ery T, Peng J, Ramanathan Y, Marshall N, Marshall T, Amendt B, Mathews MB, Price DH: Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev 1997, 11:2622-2632.
40. Mancebo HS, Lee G, Flygare J, Tomassini J, Luu P, Zhu Y, Peng J, Blau C, Hazuda D, Price D, Flores O: P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Gene Dev 1997, 11:2633-2644.
41. Wei P, Garber ME, Fang SM, Fischer WH, Jones KA: A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 1998, 92:451-462.
42. Pollard VW, Malim MH: The HIV-1 Rev protein. Annu Rev Microbiol 1998, 52:491-532.
43. Malim MH, Hauber J, Le SY, Maizel JV, Cullen BR: The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 1989, 338:254-257.
44. Kjems J, Askjaer P: Rev protein and its cellular partners. Adv Pharmacol 2000, 48:251-298.
45. Pomerantz RJ, Seshamma T, Trono D: Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency. J Virol 1992, 66:1809-1813.
46. Shaw GM, Hahn BH, Arya SK, Groopman JE, Gallo RC, Wong-Staal F: Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science 1984, 226:1165-1171.
47. Pauza CD, Galindo JE, Richman DD: Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells. J Exp Med 1990, 172:1035-1042.
48. Pang S, Koyanagi Y, Miles S, Wiley C, Vinters HV, Chen IS: High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature 1990, 343:85-89.
49. Teo I, Veryard C, Barnes H, An SF, Jones M, Lantos PL, Luthert P, Shaunak S: Circular forms of unintegrated human immunodeficiency virus type 1 DNA and high levels of viral protein expression: association with dementia and multinucleated giant cells in the brains of patients with AIDS. J Virol 1997, 71:2928-2933.
50. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch-Crovo P, Siliciano RF: Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection [see comments]. Nature 1997, 387:183-188.
51. Varmus HE, Guntaka RV, Deng CT, Bishop JM: Synthesis, structure and function of avian sarcoma virus-specific DNA in permissive and nonpermissive cells. Cold Spring Harb Symp Quant Biol 1975, 39:987-996.
52. Guntaka RV, Mahy BW, Bishop JM, Varmus HE: Ethidium bromide inhibits appearance of closed circular viral DNA and integration of virus-specific DNA in duck cells infected by avian sarcoma virus. Nature 1975, 253:507-511.
53. Gianni AM, Smotkin D, Weinberg RA: Murine leukemia virus: detection of unintegrated double-stranded DNA forms of the provirus. Proc Natl Acad Sci U S A 1975, 72:447-451.
54. Guntaka RV, Richards OC, Shank PR, Kung HJ, Davidson N: Covalently closed circular DNA of avian sarcoma virus: purification from nuclei of infected quail tumor cells and measurement by electron microscopy and gel electrophoresis. J Mol Biol 1976, 106:337-357.
55. Bukrinsky MI, Sharova N, Dempsey MP, Stanwick TL, Bukrinskaya AG, Haggerty S, Stevenson M: Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci U S A 1992, 89:6580-6584.
56. Bukrinsky MI, Haggerty S, Dempsey MP, Sharova N, Adzhubel A, Spitz L, Lewis P, Goldfarb D, Emerman M, Stevenson M: A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells [see comments]. Nature 1993, 365:666-669.
57. Shank PR, Hughes SH, Kung HJ, Majors JE, Quintrell N, Guntaka RV, Bishop JM, Varmus HE: Mapping unintegrated avian sarcoma virus DNA: termini of linear DNA bear 300 nucleotides present once or twice in two species of circular DNA. Cell 1978, 15:1383-1395.
58. Yoshimura FK, Weinberg RA: Restriction endonuclease cleavage of linear and closed circular murine leukemia viral DNAs: discovery of a smaller circular form. Cell 1979, 16:323-332.
59. Gianni AM, Weinberg RA: Partially single-stranded form of free Moloney viral DNA. Nature 1975, 255:646-648.
60. Shoemaker C, Goff S, Gilboa E, Paskind M, Mitra SW, Baltimore D: Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: implications for retrovirus integration. Proc Natl Acad Sci U S A 1980, 77:3932-3936.
61. Katz RA, Omer CA, Weis JH, Mitsialis SA, Faras AJ, Guntaka RV: Restriction endonuclease and nucleotide sequence analyses of molecularly cloned unintegrated avian tumor virus DNA: structure of large terminal repeats in circle junctions. J Virol 1982, 42:346-351.
62. Farnet CM, Haseltine WA: Circularization of human immunodeficiency virus type 1 DNA in vitro. J Virol 1991, 65:6942-6952.
63. Swanstrom R, DeLorbe WJ, Bishop JM, Varmus HE: Nucleotide sequence of cloned unintegrated avian sarcoma virus DNA: viral DNA contains direct and inverted repeats similar to those in transposable elements. Proc Natl Acad Sci U S A 1981, 78:124-128.
64. Lee YM, Coffin JM: Efficient autointegration of avian retrovirus DNA in vitro. J Virol 1990, 64:5958-5965.
65. Shoemaker C, Goff S, Gilboa E, Paskind M, Mitra SW, Baltimore D: Structure of cloned retroviral circular DNAs: implications for virus integration. Cold Spring Harb Symp Quant Biol 1981, 45:711-717.
66. Li L, Olvera JM, Yoder KE, Mitchell RS, Butler SL, Lieber M, Martin SL, Bushman FD: Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection. Embo J 2001, 20:3272-3281.
67. Dina D, Benz E. W., Jr.: Structure of murine sarcoma virus DNA replicative intermediates synthesized in vitro. J Virol 1980, 33:377-389.
68. Gilboa E, Goff S, Shields A, Yoshimura F, Mitra S, Baltimore D: In vitro synthesis of a 9 kbp terminally redundant DNA carrying the infectivity of Moloney murine leukemia virus. Cell 1979, 16:863-874.
69. Junghans RP, Boone LR, Skalka AM: Products of reverse transcription in avian retrovirus analyzed by electron microscopy. J Virol 1982, 43:544-554.
70. Campbell A: Some general questions about movable elements and their implications. Cold Spring Harb Symp Quant Biol 1981, 45:1-9.
71. Panganiban AT, Temin HM: Circles with two tandem LTRs are precursors to integrated retrovirus DNA. Cell 1984, 36:673-679.
72. Brown PO, Bowerman B, Varmus HE, Bishop JM: Correct integration of retroviral DNA in vitro. Cell 1987, 49:347-356.
73. Lobel LI, Murphy JE, Goff SP: The palindromic LTR-LTR junction of Moloney murine leukemia virus is not an efficient substrate for proviral integration. J Virol 1989, 63:2629-2637.
74. Ellis J, Bernstein A: Retrovirus vectors containing an internal attachment site: evidence that circles are not intermediates to murine retrovirus integration. J Virol 1989, 63:2844-2846.
75. Bukrinsky M, Sharova N, Stevenson M: Human immunodeficiency virus type 1 2-LTR circles reside in a nucleoprotein complex which is different from the preintegration complex. J Virol 1993, 67:6863-6865.
76. Pauza CD, Trivedi P, McKechnie TS, Richman DD, Graziano FM: 2-LTR circular viral DNA as a marker for human immunodeficiency virus type 1 infection in vivo. Virology 1994, 205:470-478.
77. Sharkey ME, Teo I, Greenough T, Sharova N, Luzuriaga K, Sullivan JL, Bucy RP, Kostrikis LG, Haase A, Veryard C, Davaro RE, Cheeseman SH, Daly JS, Bova C, Ellison R. T., 3rd, Mady B, Lai KK, Moyle G, Nelson M, Gazzard B, Shaunak S, Stevenson M: Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy. Nat Med 2000, 6:76-81.
78. Zazzi M, Romano L, Catucci M, Venturi G, De Milito A, Almi P, Gonnelli A, Rubino M, Occhini U, Valensin PE: Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression. J Med Virol 1997, 52:20-25.
79. Panther LA, Coombs RW, Aung SA, dela Rosa C, Gretch D, Corey L: Unintegrated HIV-1 circular 2-LTR proviral DNA as a marker of recently infected cells: relative effect of recombinant CD4, zidovudine, and saquinavir in vitro. J Med Virol 1999, 58:165-173.
80. Butler SL, Johnson EP, Bushman FD: Human immunodeficiency virus cDNA metabolism: notable stability of two- long terminal repeat circles. J Virol 2002, 76:3739-3747.
81. Pierson TC, Kieffer TL, Ruff CT, Buck C, Gange SJ, Siliciano RF: Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication. J Virol 2002, 76:4138-4144.
82. Stevenson M, Haggerty S, Lamonica CA, Meier CM, Welch SK, Wasiak AJ: Integration is not necessary for expression of human immunodeficiency virus type 1 protein products. J Virol 1990, 64:2421-2425.
83. Stevenson M, Stanwick TL, Dempsey MP, Lamonica CA: HIV-1 replication is controlled at the level of T cell activation and proviral integration. Embo J 1990, 9:1551-1560.
84. Wu Y, Marsh JW: Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science 2001, 293:1503-1506.
85. Spina CA, Guatelli JC, Richman DD: Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro. J Virol 1995, 69:2977-2988.
86. Wu Y, Marsh JW: Early transcription from nonintegrated DNA in human immunodeficiency virus infection. J Virol 2003, 77:10376-10382.
87. Saenz DT, Loewen N, Peretz M, Whitwam T, Barraza R, Howell KG, Holmes JM, Good M, Poeschla EM: Unintegrated lentivirus DNA persistence and accessibility to expression in nondividing cells: analysis with class I integrase mutants. Journal of Virology 2004, 78:2906-2920.
88. Cara A, Cereseto A, Lori F, Reitz M. S., Jr.: HIV-1 protein expression from synthetic circles of DNA mimicking the extrachromosomal forms of viral DNA. J Biol Chem 1996, 271:5393-5397.
89. Luciw PA, Oppermann H, Bishop JM, Varmus HE: Integration and expression of several molecular forms of Rous sarcoma virus DNA used for transfection of mouse cells. Mol Cell Biol 1984, 4:1260-1269.
90. Butler SL, Hansen MS, Bushman FD: A quantitative assay for HIV DNA integration in vivo. Nat Med 2001, 7:631-634.
91. Yedavalli VS, Benkirane M, Jeang KT: Tat and trans-activation-responsive (TAR) RNA-independent induction of HIV-1 long terminal repeat by human and murine cyclin T1 requires Sp1. J Biol Chem 2003, 278:6404-6410.
92. Chowers MY, Pandori MW, Spina CA, Richman DD, Guatelli JC: The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation. Virology 1995, 212:451-457.
93. Rasola A. Gramaglia D. Boccaccio C. Conoglio P. M.: Apoptosis enhancement by the HIV-1 Nef protein. J Immu 2001, 166:81-88.
94. Ott M, Emiliani S, Van Lint C, Herbein G, Lovett J, Chirmule N, McCloskey T, Pahwa S, Verdin E: Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway. Science 1997, 275:1481-1485.
95. Fang JY, Mikovits JA, Bagni R, Petrow-Sadowski CL, Ruscetti FW: Infection of lymphoid cells by integration-defective human immunodeficiency virus type 1 increases de novo methylation. J Virol 2001, 75:9753-9761.
96. Keshet E, Temin HM: Cell killing by spleen necrosis virus is correlated with a transient accumulation of spleen necrosis virus DNA. J Virol 1979, 31:376-388.
97. Weller SK, Joy AE, Temin HM: Correlation between cell killing and massive second-round superinfection by members of some subgroups of avian leukosis virus. J Virol 1980, 33:494-506.
98. Mullins JI, Chen CS, Hoover EA: Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS. Nature 1986, 319:333-336.
99. Rice NR, Lequarre AS, Casey JW, Lahn S, Stephens RM, Edwards J: Viral DNA in horses infected with equine infectious anemia virus. J Virol 1989, 63:5194-5200.
100. Bergeron L, Sodroski J: Dissociation of unintegrated viral DNA accumulation from single-cell lysis induced by human immunodeficiency virus type 1. Journal of Virology 1992, 66:5777-5787.
101. Panther LA, Coombs RW, Zeh JE, Collier AC, Corey L: Unintegrated circular HIV-1 DNA in the peripheral mononuclear cells of HIV-1-infected subjects: association with high levels of plasma HIV-1 RNA, rapid decline in CD4 count, and clinical progression to AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 17:303-313.
102. Li Z, Dullmann J, Schiedlmeier B, Schmidt M, von Kalle C, Meyer J, Forster M, Stocking C, Wahlers A, Frank O, Ostertag W, Kuhlcke K, Eckert HG, Fehse B, Baum C: Murine leukemia induced by retroviral gene marking. Science 2002, 296:497.
103. Lu R, Nakajima N, Hofmann W, Benkirane M, Jeang KT, Sodroski J, Engelman A, Teh-Jeang K: Simian virus 40-based replication of catalytically inactive human immunodeficiency virus type 1 integrase mutants in nonpermissive T cells and monocyte-derived macrophages.[erratum appears in J Virol. 2004 Mar;78(5):2654 Note: Teh-Jeang Kuan [corrected to Jeang Kuan-Teh]. J Virol 2004, 78:658-668.
104. Smith SM: HIV vaccine development in the nonhuman primate model of AIDS. J Biomed Sci 2002, 9:100-111.
105. Lu W, Wu X, Lu Y, Guo W, Andrieu JM: Therapeutic dendritic-cell vaccine for simian AIDS. Nat Med 2003, 9:27-32.
106. West MJ, Karn J: Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer. EMBO J 1999, 18:1378-1386.